Ghent University Academic Bibliography

Your filters: cql: author="BELAICHE, J" or (type any "bookEditor issueEditor" and editor="BELAICHE, J")

Add to list
- Journal Article
- A1
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

JC BARRETT, S HANSOUL, DL NICOLAE, JH CHO, RH DUERR, JD RIOUX, SR BRANT, MS SILVERBERG, KD TAYLOR, MM BARMADA, et al.

(2008) NATURE GENETICS. 40(8). p.955-962
Add to list
- Journal Article
- A1
Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4

C LIBIOULLE, E LOUIS, S HANSOUL, C SANDOR, F FARNIR, D FRANCHIMONT, S VERMEIRE, O DEWIT, Martine De Vos (UGent) , A DIXON, et al.

(2007) PLOS GENETICS. 3(4).
Add to list
- Conference Paper
- C3
Radiological sacroiliitis in Crohn's disease: A multicenter association study

Harald Peeters, Bert Vander Cruyssen (UGent) , Herman Mielants (UGent) , Kurt De Vlam (UGent) , S VERMEIRE, E LOUIS, P RUTGEERTS, J BELAICHE and Martine De Vos (UGent)

(2006) GASTROENTEROLOGY. 130(4).
Add to list
- Journal Article
- A1
Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study

V DIDEBERG, E LOUIS, F FARNIR, S BERTOLI, S VERMEIRE, P RUTGEERTS, Martine De Vos (UGent) , A VAN GOSSUM, J BELAICHE and V BOURS

(2006) PHARMACOGENETICS AND GENOMICS. 16(5). p.369-373
Add to list
- Conference Paper
- C3
The TNF/Adam 17 system: Implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease

V DIDEBERG, E THEATRE, F FARNIR, S VERMEIRE, P RUTGEERTS, Martine De Vos (UGent) , J BELAICHE, A VAN GOSSUM, D FRANCHIMONT, E LOUIS, et al.

(2006) GASTROENTEROLOGY. 130(4).
Add to list
- Journal Article
- A1
No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease

S WILLOT, S VERMEIRE, M OHRESSER, P RUTGEERTS, G PAINTAUD, J BELAICHE, Martine De Vos (UGent) , A VAN GOSSUM, D FRANCHIMONT, JF COLOMBEL, et al.

(2006) PHARMACOGENETICS AND GENOMICS. 16(1). p.37-42
Add to list
- Journal Article
- A1
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease

E LOUIS, Z EL GHOUL, S VERMEIRE, S DALL'OZZO, P RUTGEERTS, G PAINTAUD, J BELAICHE, Martine De Vos (UGent) , A VAN GOSSUM, JF COLOMBEL, et al.

(2004) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 19(5). p.511-519
Add to list
- Journal Article
- A1
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

N FRANCHIMONT, V PUTZEYS, J COLLETTE, S VERMEIRE, P RUTGEERTS, Martine De Vos (UGent) , A VAN GOSSUM, D FRANCHIMONT, R FIASSE, P PELCKMANS, et al.

(2004) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 20(6). p.607-614
Add to list
- Journal Article
- A1
Treatment of acute diarrhoea: update of guidelines based on a critical interuniversity assessment of medications and current practices

D URBAIN, J BELAICHE, Martine De Vos (UGent) , R FIASSE, M HIELE, S HUIJGHEBAERT, F JACOBS, H MALONNE, P SPEELMAN, A VAN GOMPEL, et al.

(2003) ACTA GASTRO-ENTEROLOGICA BELGICA. 66(3). p.218-226
Add to list
- Journal Article
- A1
Observational survey of NSAID-related upper gastro-intestinal adverse events in Belgium.

J BELAICHE, A BURETTE, Martine De Vos (UGent) , E LOUIS, M HUYBRECHTS and M DELTENRE

(2002) ACTA GASTRO-ENTEROLOGICA BELGICA. 65(2). p.65-73

Academic Bibliography

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4

Radiological sacroiliitis in Crohn's disease: A multicenter association study

Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study

The TNF/Adam 17 system: Implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease

No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

Treatment of acute diarrhoea: update of guidelines based on a critical interuniversity assessment of medications and current practices

Observational survey of NSAID-related upper gastro-intestinal adverse events in Belgium.

Contents

Support

Contact